Case-control Consortia

NCI encourages development of case-control consortia to further study of gene-gene and gene-environment interactions in the etiology of cancer. Investigators may come together informally at first to discuss shared interests as has occurred, for example, for brain tumors. In time, a formal structure may evolve, as with the International Consortium of Investigators Working on Non-Hodgkin's Lymphoma Epidemiologic Studies (InterLymph Consortium).

Consortia arrangements can make possible study of less common cancers and cancers of high lethality for which it is difficult, if not impossible, for individual investigators to recruit sufficient study participants.

Contact Us

To discuss potential consortia arrangements, investigators may contact Edward Trapido, Sc.D., Associate Director of the Epidemiology and Genetics Research Program (EGRP).

DCEG is a partner in this initiative.